Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Flavonoids and other polyphenolic compounds have been shown to inhibit human topoisomerase IB (topo I) through both inhibition of relaxation activity and through stabilization of the cleavable complex (poisoning). Some flavonoids have also been shown to intercalate DNA, and an association of topoisomerase inhibition with intercalation has been noted. We surveyed 34 polyphenolic compounds, primarily flavonoid glycones and aglycones, for their ability to inhibit topo I and to intercalate DNA using an in vitro gel electrophoresis method. We show that the most potent topo I poisons are the flavones and flavonols, and that these generally, but not always, are found to be DNA intercalators. There was no clear correlation, however, of topo-I-poisoning activity with the degree of DNA unwinding. Surprisingly, both DNA intercalation and topo I poisoning were shown to occur with some flavone glycones, including the C-glycosylflavone orientin. Inhibition of relaxation activity by flavonoids was found to be difficult to quantify and was most likely to be due to non-specific inhibition through flavonoid aggregation. As part of a structure–activity analysis, we also investigated the acid–base chemistry of flavonoids and determined that many flavonoids show acid–base activity with a pKa in the physiological pH region. For this reason, subtle pH changes can have significant effects on solution activity of flavonoids and their concomitant biological activity. In addition, these effects may be complicated by pH-dependent aggregation and oxidative degradation. Finally, we develop a simple model for the intercalation of flavonoids into DNA and discuss possible consequences of intercalation and topoisomerase inhibition on a number of cellular processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Dietary Intake and Bioavailability of Polyphenols
Scalbert, A., & Williamson, G. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.8.2073s · Cited by 3,658
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Structural aspects of antioxidant activity of flavonoids
Van Acker, S. A. B. E., Van Den Berg, D.-J., Tromp, M. N. J. L., Griffioen, D. H., Van Bennekom, W. P., Van Der Vijgh, W. J. F., & Bast, A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02047-0 · Cited by 1,341
Mechanisms of transcription-coupled DNA repair
Svejstrup, J. Q. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm703 · Cited by 380
Research works printed but not linked: 42
- Formica, 1995, Review of the biology of quercetin and related bioflavonoids, Food Chem. Toxicol., 33, 1061, 10.1016/0278-6915(95)00077-1 · DOI · Paper page
- Nijveldt, 2001, Flavonoids: a review of probable mechanisms of action and potential applications, Am. J. Clin. Nutr., 74, 418, 10.1093/ajcn/74.4.418 · DOI · Paper page
- Ferguson, 2001, Role of plant polyphenols in genomic stability, Mutat. Res., 475, 89, 10.1016/S0027-5107(01)00073-2 · DOI · Paper page
- Le Marchand, 2002, Cancer preventive effects of flavonoids – a review, Biomed. Pharmacother., 56, 296, 10.1016/S0753-3322(02)00186-5 · DOI · Paper page
- Manach, 1996, Bioavailability, metabolism, and physiological impact of 4-oxo-flavonoids, Nutr. Res., 16, 517, 10.1016/0271-5317(96)00032-2 · DOI · Paper page
- Galati, 2002, Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics, Toxicology, 177, 91, 10.1016/S0300-483X(02)00198-1 · DOI · Paper page
- Boege, 1996, Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I, J. Biol. Chem., 271, 2262, 10.1074/jbc.271.4.2262 · DOI · Paper page
- Yamashita, 1990, Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol, Biochem. Pharmacol., 39, 737, 10.1016/0006-2952(90)90153-C · DOI · Paper page
- Wang, 2002, Cellular roles of DNA topoisomerases: a molecular perspective, Nat. Rev. Mol. Cell Biol., 3, 430, 10.1038/nrm831 · DOI · Paper page
- Trask, 1988, Stabilization of type I topoisomerase–DNA covalent complexes by actinomycin D, Proc. Natl. Acad. Sci. U.S.A., 85, 1417, 10.1073/pnas.85.5.1417 · DOI · Paper page
- Lehmann, 2003, Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster, Mutat. Res., 539, 167, 10.1016/S1383-5718(03)00162-1 · DOI
- Sabourin, 2003, Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks, Nucleic Acids Res., 31, 4373, 10.1093/nar/gkg497 · DOI
- Wu, 2003, The Bloom's syndrome helicase suppresses crossing over during homologous recombination, Nature (London), 426, 870, 10.1038/nature02253 · DOI · Paper page
- Strick, 2000, Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia, Proc. Natl. Acad. Sci. U.S.A., 97, 4790, 10.1073/pnas.070061297 · DOI · Paper page
- Peterson, 2003, Flavonoid intake and breast cancer risk: a case-control study in Greece, Br. J. Cancer, 89, 1255, 10.1038/sj.bjc.6601271 · DOI · Paper page
- Constantinou, 1995, Flavonoids as DNA topoisomerase antogonists and poisons – structure–activity-relationships, J. Nat. Prod., 58, 217, 10.1021/np50116a009 · DOI · Paper page
- Webb, 2003, A gel electrophoresis assay for the simultaneous determination of topoisomerase I inhibition and DNA intercalation, Anal. Biochem., 321, 22, 10.1016/S0003-2697(03)00459-7 · DOI
- Sober, 1968, Buffer solutions
- Hertzberg, 1989, On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme–DNA complex, Biochemistry, 28, 4629, 10.1021/bi00437a018 · DOI · Paper page
- McGovern, 2002, A specific mechanism of nonspecific inhibition, J. Med. Chem., 45, 1712, 10.1021/jm010533y · DOI · Paper page
- Jovanovic, 1994, Flavonoids as antioxidants, J. Am. Chem. Soc., 116, 4846, 10.1021/ja00090a032 · DOI · Paper page
- Wagner, 1976, 13C-NMR-spektren natuerlich vorkommender flavonoide, Tetrahedron Lett., 21, 1799, 10.1016/S0040-4039(00)93787-0 · doi:10.1016/s0040-4039(00)93787-0
- Dangles, 2001, Binding of flavonoids to plasma proteins, Methods Enzymol., 335, 319, 10.1016/S0076-6879(01)35254-0 · DOI
- Mocek, 1972, Kinetics and mechanism of quercetin oxidation, J. Inst. Brew., 78, 459, 10.1002/j.2050-0416.1972.tb03481.x · doi:10.1002/j.2050-0416.1972.tb03481.x
- Bailly, 1999, Intercalation into DNA is not required for inhibition of topoisomerase I by indolocarbazole antitumor agents, Cancer Res., 59, 2853
- Snyder, 2002, Evaluation of the clastogenic, DNA intercalative and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells, Environ. Mol. Mutagen., 40, 266, 10.1002/em.10121 · DOI · Paper page
- Rueff, 1986, Genetic toxicology of flavonoids: the role of metabolic conditions in the induction of reverse mutation, SOS functions and sister-chromatid exchanges, Mutagenesis, 1, 179, 10.1093/mutage/1.3.179 · DOI
- Popp, 1991, Induction of sister-chromatid exchanges (SCE), polyploidy, and micronuclei by plant flavonoids in human lymphocyte cultures: a comparative study of 19 flavonoids, Mutat. Res., 246, 205, 10.1016/0027-5107(91)90123-6 · DOI
- Pilch, 1997, Minor groove-directed and intercalative ligand–DNA interactions in the poisoning of human DNA topoisomerase I by protoberberine analogs, Biochemistry, 36, 12542, 10.1021/bi971272q · doi:10.1021/bi971272q
- Burda, 2001, Antioxidant and antiradical activities of flavonoids, J. Agric. Food Chem., 49, 2774, 10.1021/jf001413m · DOI · Paper page
- Wilson, 1999, DNA intercalators, 427, 10.1016/B978-0-08-091283-7.00067-9 · DOI
- Austin, 1992, Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives, Biochem. J., 282, 883, 10.1042/bj2820883 · DOI · Paper page
- Harmon, 1999, RecQ helicase and topoisomerase III comprise a novel DNA strand passage function: a conserved mechanism for control of DNA recombination, Mol. Cell, 3, 611, 10.1016/S1097-2765(00)80354-8 · DOI
- Silva, 2000, Chemical features of flavonols affecting their genotoxicity: potential implications in their use as therapeutical agents, Chem. Biol. Interact., 124, 29, 10.1016/S0009-2797(99)00139-8 · DOI
- Uhl, 2003, Effect of chrysin, a flavonoid compound, on the mutagenic activity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and benzo(a)pyrene (B(a)P) in bacterial and human hepatoma (HepG2) cells, Arch. Toxicol., 77, 477, 10.1007/s00204-003-0469-4 · doi:10.1007/s00204-003-0469-4
- Edenharder, 2003, Inhibition of clastogenicity of benzo[a]pyrene and of its trans-7,8-dihydrodiol in mice in vivo by fruits, vegetables, and flavonoids, Mutat. Res., 537, 169, 10.1016/S1383-5718(03)00078-0 · DOI
- Ebeler, 2002, Dietary catechin delays tumor onset in a transgenic mouse model, Am. J. Clin. Nutr., 76, 865, 10.1093/ajcn/76.4.865 · DOI
- Kuntz, 1999, Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines, Eur. J. Nutr., 38, 133, 10.1007/s003940050054 · DOI · Paper page
- Wang, 1999, Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukemia HL-60 cells, Eur. J. Cancer., 35, 1517, 10.1016/S0959-8049(99)00168-9 · DOI · Paper page
- Calabrese, 1998, Can the concept of hormesis be generalized to carcinogenesis?, Regul. Toxicol. Pharmacol., 28, 230, 10.1006/rtph.1998.1267 · doi:10.1006/rtph.1998.1267
- Soe, 2003, p53 stimulates human topoisomerase I activity by modulating its DNA binding, Nucleic Acids Res., 31, 6585, 10.1093/nar/gkg846 · doi:10.1093/nar/gkg846
- Laine, 2003, Werner protein stimulates topoisomerase I DNA relaxation activity, Cancer Res., 63, 7136
Cited by
Distribution and biological activities of the flavonoid luteolin
Lopez-Lazaro, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787001712 · Cited by 1,106
“DNA topoisomerase (topo) inhibitors are efficient inducers of apoptosis in cancer cells [207] and several works have reported that luteolin inhibits and poisons topo I and topo II [117, 205, 208-213].”
BackgroundFlavonoids as prospective compounds for anti-cancer therapy
Ravishankar, D., Rajora, A. K., Greco, F., & Osborn, H. M. I. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.10.004 · Cited by 572
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Song, X., Zhao, Y., Hou, S., Xu, F., Zhao, R., He, J., Cai, Z., Li, Y., & Chen, Q. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.01.013 · Cited by 309
Rescifina, A., Zagni, C., Varrica, M. G., Pistarà, V., & Corsaro, A. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.029 · Cited by 274
Metadata
- Authors
- WEBB, M. R., & EBELER, S. E.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2004-12-07
- Volume
- 384
- Issue
- 3
- Pages
- 527-541
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1967936457
- Cited by
- 145
- References
- 5
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity. https://app.cochat.ai/papers/10.1042/bj20040474
- The paper
- WEBB, M. R., & EBELER, S. E. (2004). Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity. Biochemical Journal. https://doi.org/10.1042/bj20040474
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.